Inhibikase Therapeutics, Inc. (IKT) SEC Filings https://www.inhibikase.com/investors/sec-filings/section-16-filings/rss Inhibikase Therapeutics, Inc. (IKT) - Section 16 Filings en-us https://d1io3yog0oux5.cloudfront.net/inhibikase/files/theme/images/logo-sm.png Inhibikase Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068079/0001193125-26-068079.pdf Tue, 24 Feb 26 20:54:53 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068079/0001193125-26-068079.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068077/0001193125-26-068077.pdf Tue, 24 Feb 26 20:54:08 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068077/0001193125-26-068077.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068063/0001193125-26-068063.pdf Tue, 24 Feb 26 20:49:21 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-068063/0001193125-26-068063.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-006351/0001193125-26-006351.pdf Wed, 07 Jan 26 16:23:48 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-006351/0001193125-26-006351.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-006350/0001193125-26-006350.pdf Wed, 07 Jan 26 16:22:21 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-006350/0001193125-26-006350.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-006343/0001193125-26-006343.pdf Wed, 07 Jan 26 16:19:48 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-26-006343/0001193125-26-006343.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001875620-25-000025/0001875620-25-000025.pdf Mon, 24 Nov 25 15:47:31 -0500 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001875620-25-000025/0001875620-25-000025.pdf <![CDATA[3/A - Initial statement of beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-191465/0001193125-25-191465.pdf Thu, 28 Aug 25 19:52:39 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-191465/0001193125-25-191465.pdf <![CDATA[3/A - Initial statement of beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-191464/0001193125-25-191464.pdf Thu, 28 Aug 25 19:50:47 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-191464/0001193125-25-191464.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-191463/0001193125-25-191463.pdf Thu, 28 Aug 25 19:48:44 -0400 https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-25-191463/0001193125-25-191463.pdf